These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38326175)

  • 1. National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.
    Palamar JJ; Fitzgerald ND; Carr TH; Rutherford C; Keyes KM; Cottler LB
    Drug Alcohol Depend; 2024 May; 258():111086. PubMed ID: 38326175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National and regional trends in fentanyl seizures in the United States, 2017-2023.
    Palamar JJ; Fitzgerald N; Carr TH; Cottler LB; Ciccarone D
    Int J Drug Policy; 2024 May; ():104417. PubMed ID: 38744553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021.
    Palamar JJ; Ciccarone D; Rutherford C; Keyes KM; Carr TH; Cottler LB
    Drug Alcohol Depend; 2022 May; 234():109398. PubMed ID: 35370014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.
    Keyes KM; Patrick ME
    Addiction; 2023 Dec; 118(12):2449-2454. PubMed ID: 37287110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping review of law enforcement drug seizures and overdose mortality in the United States.
    Cano M; Timmons P; Hooten M; Sweeney K; Oh S
    Int J Drug Policy; 2024 Feb; 124():104321. PubMed ID: 38211403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifts in drug seizures in the United States during the COVID-19 pandemic.
    Palamar JJ; Le A; Carr TH; Cottler LB
    Drug Alcohol Depend; 2021 Apr; 221():108580. PubMed ID: 33674175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Your brain on shrooms - how psilocybin resets neural networks.
    Kozlov M
    Nature; 2024 Jul; 631(8022):721. PubMed ID: 39020195
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.
    Palamar JJ; Le A; Cleland CM; Keyes KM
    Int J Drug Policy; 2023 May; 115():104001. PubMed ID: 36934660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012-2017: implications for policy and regulatory change.
    Bonny-Noach H; Berkovitz R; Shapira B
    Isr J Health Policy Res; 2020 May; 9(1):14. PubMed ID: 32362275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade.
    Farah R; Kerns AF; Murray AC; Holstege CP
    J Adolesc Health; 2024 May; 74(5):1053-1056. PubMed ID: 38416101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
    Leonard JB; Anderson B; Klein-Schwartz W
    J Psychopharmacol; 2018 Dec; 32(12):1286-1294. PubMed ID: 30182795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
    Belouin SJ; Averill LA; Henningfield JE; Xenakis SN; Donato I; Grob CS; Berger A; Magar V; Danforth AL; Anderson BT
    Neuropharmacology; 2022 Nov; 219():109214. PubMed ID: 35973601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J; Winstock A; Hunt N; Mitcheson L
    Eur Addict Res; 2007; 13(1):57-64. PubMed ID: 17172780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.
    Bhuiya NMA; Jacobs RJ; Wang K; Sun Y; Nava B; Sampiere L; Yerubandi A; Caballero J
    Cureus; 2023 Sep; 15(9):e45169. PubMed ID: 37842360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy in focus: Is psilocybin the next cannabis?
    Basky G
    CMAJ; 2021 Nov; 193(45):E1741-E1742. PubMed ID: 34782381
    [No Abstract]   [Full Text] [Related]  

  • 16. Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):66-73. PubMed ID: 35090364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
    Bogenschutz MP; Forcehimes AA; Pommy JA; Wilcox CE; Barbosa PC; Strassman RJ
    J Psychopharmacol; 2015 Mar; 29(3):289-99. PubMed ID: 25586396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associations of classic psychedelic-related seizures in a population-based sample.
    Simonsson O; Goldberg SB; Chambers R; Osika W; Long DM; Hendricks PS
    Drug Alcohol Depend; 2022 Oct; 239():109586. PubMed ID: 35981469
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.